Sterling Winthrop Consumer Health Group
Executive Summary
William Pietersen to exec VP and president of the consumer health group, effective at the "end of January." He succeeds Herbert McKenzie who retired Dec. 31 to pursue personal interests. Most recently president of the Seagram Beverage Group of Joseph E. Seagram & Sons, Pietersen also has held management positions with Guinness America and the Unilever Group. Sterling divided its operations into separate pharmaceutical and consumer health product lines in early 1992. Goals for the consumer business include having 75% of established brands in the top three market positions by 1996; having sales grow three percentage points faster than the market; and being among the top three OTC firms worldwide in terms of operating profits ("The Pink Sheet" Sept. 7, p. 15).
You may also be interested in...
Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA Skin Infections Guidance Spurs Debate On Endpoint Relevance
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials
Shire Hopes To Sow Future Deals With $50M Venture Fund
Specialty drug maker Shire has quietly begun scouting deals with a brand-new $50 million venture fund, the latest of several in-house investment arms to launch with their parent company's pipelines, not profits, as the measure of their worth